Chemoinformaics analysis of 2,3,3-Trimethyloctane
| Molecular Weight | 156.313 | nRot | 5 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 7 |
| Exact Molecular Weight | 156.188 | nRing | 0 |
| Solubility: LogS | -2.247 | nHRing | 0 |
| Solubility: LogP | 2.821 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 34.373 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.678 |
| Synth | 1.469 |
| Natural Product Likeliness | -0.224 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.329 |
| MDCK | 0.0000334 |
| BBB | 0.572 |
| PPB | 0.914476 |
| VDSS | 1.194 |
| FU | 0.0724261 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.568 |
| CYP2c19-inh | 0.752 |
| CYP2c19-sub | 0.2 |
| CYP2c9-inh | 0.415 |
| CYP2c9-sub | 0.724 |
| CYP2d6-inh | 0.528 |
| CYP2d6-sub | 0.383 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.193 |
| CL | 13.334 |
| T12 | 0.786 |
| hERG | 0.022 |
| Ames | 0.047 |
| ROA | 0.023 |
| SkinSen | 0.293 |
| Carcinogencity | 0.175 |
| EI | 0.99 |
| Respiratory | 0.115 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.726663 |